Viewing Study NCT01691859


Ignite Creation Date: 2025-12-24 @ 2:53 PM
Ignite Modification Date: 2026-02-21 @ 11:36 PM
Study NCT ID: NCT01691859
Status: COMPLETED
Last Update Posted: 2023-06-28
First Post: 2012-09-13
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Asthma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None extension study View
None Severe refractory asthma View
None safety View
None SB-240563 View
None mepolizumab View
None eosinophils View